Finchley Healthcare Ventures
Overview
Finchley Healthcare Ventures is a Canadian venture capital fund that specializes in investments within the life sciences sector, focusing on therapeutics by investing directly in biotech companies and as a limited partner in other specialized venture capital funds.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TRIANA Biomedicines | Dec 2025 | Series B | Co-investor |
| Reverb Therapeutics | Feb 2025 | Seed | Co-investor |
| Cartography Biosciences | Oct 2025 | Series B | Co-investor |
| Coultreon Biopharma | Apr 2026 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Finchley Healthcare Ventures based?
Finchley Healthcare Ventures is headquartered in Montreal, Quebec, Canada.
When was Finchley Healthcare Ventures founded?
Finchley Healthcare Ventures was founded in 2022.
How many portfolio companies does Finchley Healthcare Ventures have?
Finchley Healthcare Ventures has 6 portfolio companies in Caplight's dataset.
What are some companies in Finchley Healthcare Ventures's portfolio?
Portfolio companies visible on Caplight include TRIANA Biomedicines, Reverb Therapeutics, Cartography Biosciences, Coultreon Biopharma.
What was Finchley Healthcare Ventures's most recent investment shown here?
Finchley Healthcare Ventures's most recent investment in this portfolio sample was in Coultreon Biopharma in 2026.
What sectors does Finchley Healthcare Ventures focus on?
Finchley Healthcare Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Finchley Healthcare Ventures focus on?
Finchley Healthcare Ventures typically invests at the Mid stage.